Antimycobacterial drugs Flashcards
first line drugs for tuberculosis
rifampin
pyrazinamide
ethambutol
isoniazid
second line drugs for tuberculosis
rifabutin rifapentine fluoroquinolone capreomycine ethionamide amikacin kanamycin
ISONIAZID ROA
oral
parenterally
isoniazid MOA
inhibit synthesis of mycolic acid
activated by catalase-peroxidase encoded by KatG gene
resistance to isoniazid
mutation of the KatG gene
isoniazid bactericidal or bacteriostatic?
bactericidal
isoniazid indication
bactericidal - M. tuberculosis and M.kansasii
M. avium-intracellulare
LATENT TB
prevent TB in neonates and children in close contact
prophylaxis: if + for tuberculin, HIV+ and recent exposure
AE isoniazid
Hepatitis (age dependent)
Peripheral neuritis: drug induced pyridoxine deficiency (B6) (paresthesia, numb finger and toe)
RARE: toxic encephalopathy and hematologic; granulocytosis, anemia, thrombocytopenia
ETHAMBUTOL bactericidal or bacteriostatic?
bacteriostatic
ethambutol roa
orally (w other drugs TB and M. AI
ethambutol moa
inhibit arabinosyl transferase and synthesis of arabinogalactan for cell wall
ethambutol resistance
mutation in arabinosyl transferase
AE ethambutol
Optic neuritis
impaired green-red color discrimination (retrobulbar neuritis)
CI in children to young to assess visual activity)
hyperuricemia, GOUT
hepatitis, thrombocytopenia
Pyrazinamide bactericidal or bacteriostatic?
bactericidal
pyrazinamide moa
orally given for M.TB, given in combination with isoniazid, ethambutol and rifampin
pyrazinamide MOA
nicotinamide derivative, converted in mycobacteria to active metabolite pyrazinoic acid by pyrazinamidase
inhibit fatty acid synthesis and translation
pyrazinamide resistance
mutation in pyrazinamidase
pyrazinamide AE
arthralgia
hyperuricemia and gout
hematologic toxicity
hepatitis and increase in serum ion concentration
pyrazinamide contraindicated
in pregnant women
Rifampin - broad or narrow spectrum?
broad
rifampin ROA
oral/IV
rifampin MET
converted in the liver after oral administration to active desacetyl - rifampin. widely distributed to tissue and fluid.
enterohepatic cycling
rifampin indications
M.TB -> rifampin, isoniazid, ethambutol and pyrazinamide
M.kansasii
M.AI
M.leprae
Tubercular meningitis
Latent TB (alterative isoniazid)
Prevent; exposed to H.influenza, who can transmit to children under 4 unvaccinated
Meningococcal disease - in those close contact
treat - Legionella pneumophila with macrolide or fluoroquinolone
Rifampin MOA
binds to B subunit of DNA - dependent RNA polymerase, inhibit transcription
Rifampin resistance
decreased affinity of RNA polymerase. NEVER USE ALONE
rifampin AE
hepatitis (don’t drink alcohol)
hypersensitivity, fluelike illness w chills (large doses)
nephrotoxicity (light chain proteinuria)
discontinue if purpura develops
reddish-orange-brown discoloration of SALIVA; TEAR; UriNE
induces cytochrome P450; accelerate metabolism of other drugs -> macrolides, benzodiazepines, calcium blocker, digoxin, sulfonylureas, theophylline, warfarin, estrogen
Rifapentine - what is it derived from?
derived from rifamycin
rifapentine - indication
pulmonary TB by M.TB
2 phase regimens rifapentine
twice weekly rifapentine w isoniazid, ethambutol ad pyrazinamide for 2 months
for 4 months rifapentine and isoniazid
rifabutin MOA
inhibit DNA dependent RNA polymerase
rifabutin indication
Treat TB in HIV infected (not rifampin, cannot use w protease inhibitor)
prevent M.avium-intracellulare infection
rifabutin ROA
orally w food, to avoid irritation (lipophilic)
rifabutin AE
induce cytochrome P450
bedaquiline note
can be given orally one daily for 2w and 3 w for 22 weeks. should be given in common w at least 3 other drugs to which patients isolate is susceptible
bedaquiline MOA
blocking proton pump for ATP synthase in M.TB
bedaquiline indication
MDR-TB
bedaquiline ROA
orally
bedaquiline AE
electrocardiogram bf starting, and at regular intervals after
prolonged QT; arrhythmia and sudden death: block of depolarizing K+ channels
advese liver reaction
interacts with cytochrome P450: mentoring!! e.g rifampin reduces bed aquiline, so montoring needed
monitor electrocardiogram, liver reaction and CYP450
drugs for m. avian intracellular infection
ethambutol, rifampin, rifabutin
azithromycin, clarithromycin
ciprofloxacin
used to prevent MAC infections in HIV/ immunocompetent patients
azithromycin, clarithromycin and rifabutin
CAR
drugs combined to use for MAC
pulmonary and other MAC infections:
azithromycin, ethambutol, rifabutin or rifampin (rifabutin if immunocompromised)
16-24 weeks
alternative for MAC in immunocompromised
clofazimine + streptomycin (contraindicated in pregnant women)/ amikacin
drugs for leprosy
MD therapy indicated
sulfones (dapsone) MOA
inhibit synthesis of folic acid by M.leprae (BACTERIOSTATIC)
sulfones (dapsone) ROA
orally w other drugs
sulfones (dapsone) AE
glucose 6 - phosphate deficiency - hemolytic anemia
gastrointestinal disturbances
peripheral neuropathy
optic neuritis and blurred vision
proteinuria, nephrotic syndrome, SLE like syndrome
sulfones (dapsone) MET
metabolized by acetylation. so people with high levels of acetyl-transferase activity have low level of drug
Rifampin
great bactericidal activity agains M.leprae
combined w dapsone
or dapsone+clofazimine
Clofazimine - facts
antimycobacterial and antiinflammatory effects
enhances phagocytic activity of neutrons and macro
penzydine dye
clofazimine - indications
bacteriocidal - M.TB
bacteriostatic - M.leprae
active - M.AI
Lepromatous leprosy
Clofazimine in combo w dapsone and rifampin
antiinflammatory
tuberculoid leprosy -> dapsone + rifampin
Clofazimine MET
slowly and incompletely absorbed from gut
highly lipophilic and widely distributed to tissues
70 days half-life
Clofazimine AE
Gi distress
Photosensitivity
Discoloration of body secretion and skin
Hepatitis so contraindicated in hepatic disease
Thalidomide
phocomelia
immunomodulating actions
orphan drug - TB, leprosy, erythema nodosum leprosum
ability to stimulate Tcells (CD8+)